CN Bio expands service offering to support oncology drug discovery
CN Bio, a leading organ-on-a-chip company that designs and manufactures single- and multi-organ microphysiological systems (MPS), has launched its Oncology Service in response to the global need to improve cancer drug discovery approval rates.